Please ensure Javascript is enabled for purposes of website accessibility
Accessibility Menu
Amgen Stock Quote


Price as of March 1, 2024, 4:00 p.m. ET

You’re reading a free stock page from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Amgen Return vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
AMGN +19.42% +46.65% +7.95% +26,028%
S&P +29.03% +83.23% +12.86% +1,328%

Amgen Company Info

One of the pioneers of the biotech industry, Amgen is now one of the world's largest pharmaceutical companies, with more than a dozen products focused on cancer, inflammation, neurology, cardiology, and more.

News & Analysis

The Fool has written over 1,000 articles on Amgen.


Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.